Can the dream of affordable cancer care come true?
Making the market more competitive - the potential benefit of biosimilars
The adoption of biosimilars in Oxford: a case study
Can biosimilars ensure access to drugs for everyone?
The use of trastuzumab and biosimilars in the treatment of breast cancer